ClinicalTrials.Veeva

Menu

Longterm Influence of Pediatric Long COVID Syndrome

National Taiwan University logo

National Taiwan University

Status

Enrolling

Conditions

COVID-19-Associated Encephalitis
Long COVID

Treatments

Diagnostic Test: Brain MRI

Study type

Observational

Funder types

Other

Identifiers

NCT05566392
202208086RIND

Details and patient eligibility

About

We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation

Enrollment

500 estimated patients

Sex

All

Ages

6 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 6-18 years old
  • Has been diagnosed COVID-19 before

Exclusion criteria

  • History of neuropsychiatric disorders
  • Have some device not allowed for MRI

Trial design

500 participants in 2 patient groups

Coronavirus disease (COVID)
Description:
Pediatric patients who was diagnosed as COVID
Treatment:
Diagnostic Test: Brain MRI
Healthy
Description:
Pediatric participants who hadn't been diagnosed COVID before
Treatment:
Diagnostic Test: Brain MRI

Trial contacts and locations

1

Loading...

Central trial contact

Wang-Tso Lee, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems